FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106304 [Registered on: 16/03/2026] Trial Registered Prospectively
Last Modified On: 14/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device
Unani
Other (Specify) [Therapeutic]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to compare leech therapy and platelet rich plasma therapy in patients with chronic non healing wounds 
Scientific Title of Study   Randomized Comparative Clinical Evaluation of Classical Regimen Irsal-i-‘Alaq (Hirudotherapy) versus Platelet-Rich Plasma Therapy in Qurooh-e-Muzmina (Chronic Ulcers) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mohammad Areeb 
Designation  PG Scholar 
Affiliation  Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College and Hospital 
Address  Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College Faculty of Unani Medicine Aligarh Muslim University Aligarh UTTAR PRADESH 202002 India

Aligarh
UTTAR PRADESH
202002
India 
Phone  9557676664  
Fax    
Email  areebgh6327@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Asia Sultana 
Designation  Professor 
Affiliation  Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College and Hospital 
Address  Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College Faculty of Unani Medicine Aligarh Muslim University Aligarh UTTAR PRADESH 202002 India

Aligarh
UTTAR PRADESH
202002
India 
Phone  8755199034  
Fax    
Email  aasia.sultana@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mohammad Areeb 
Designation  PG Scholar 
Affiliation  Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College and Hospital 
Address  Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College Faculty of Unani Medicine Aligarh Muslim University Aligarh UTTAR PRADESH 202002 India

Aligarh
UTTAR PRADESH
202002
India 
Phone  9557676664  
Fax    
Email  areebgh6327@gmail.com  
 
Source of Monetary or Material Support  
Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College faculty of Unani Medicine Aligarh Muslim University Aligarh UTTAR PRADESH 202002 India 
 
Primary Sponsor  
Name  Department of Ilaj Bit Tadbeer 
Address  Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College faculty of Unani Medicine Aligarh Muslim University Aligarh UTTAR PRADESH 202002 India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mohammad Areeb  Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College and Hospital  Department of Ilaj Bit Tadbeer Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh Uttar Pradesh 202002 India
Aligarh
UTTAR PRADESH 
9557676664

areebgh6327@gmail.com 
Dr Mohammad Areeb  Department of Plastic Surgery Jawaharlal Nehru Medical College and Hospital  Department of Plastic Surgery Jawaharlal Nehru Medical College and Hospital Aligarh Muslim University Aligarh Uttar Pradesh 202002 India
Aligarh
UTTAR PRADESH 
9557676664

areebgh6327@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Faculty of Unani Medicine Aligarh Muslim University Aligarh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L979||Non-pressure chronic ulcer of unspecified part of lower leg,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Leech Therapy  Leech Therapy will be performed once weekly for a total of 8 sittings over 8 weeks 
Comparator Agent  Platelets Rich Plasma (PRP) therapy  Platelets Rich Plasma (PRP) Therapy will be administered at weekly intervals for a total of 8 sessions 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Diagnosed cases of chronic ulcers
All adult patients from the age of 18yrs
Both genders
Patients having ulcers of grade II to V as per Wagner classification
HbA1C is less than 7 (controlled diabetes)
 
 
ExclusionCriteria 
Details  Pregnant and lactating women
Patients having psychological disorders
Immunocompromised patients
Patients on anticoagulant or antiplatelet therapy (aspirin warfarin clopidogrel etc)
Patients of bleeding disorders and Severe anemia (Hb less than 8 g per dL) and hypotension
Platelet dysfunction or platelet count less than 150000 per µL (for PRP group)
Known hypersensitivity to leech saliva or its components (for Leech group)
Patients who refuse to sign the consent 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the Clinical outcome of Classical Regimen Irsal-i-Alaq
(Hirudotherapy) with Platelets Rich Plasma (PRP) Therapy in Qurooh-e-Muzmina
(Chronic Ulcers)
Evaluate the effects of Platelet Rich Plasma (PRP) Therapy in the management of
Qurooh-e-Muzmina (chronic ulcers)
Evaluate the effects of Irsal-i-Alaq (Hirudotherapy) in the management of
Qurooh-e-Muzmina (chronic ulcers)
To Evaluate the post treatment change in Quality of Life of patients with Qurooh-e
Muzmina (chronic ulcers) 
Baseline and at the end of treatment after 8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Biotechnological assessment of leech saliva for characterization  Baseline
 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This randomized, open-label, comparative Phase II clinical trial aims to evaluate the effectiveness of the classical Unani regimen Irsal-i-Alaq (Hirudotherapy) in comparison with Platelet Rich Plasma (PRP) therapy in the management of Qurooh-e-Muzmina (chronic ulcers)

Chronic ulcers are wounds that fail to heal within six weeks due to factors such as impaired circulation infection or systemic diseases like diabetes In this study 50 patients aged from18 years with Wagner grade II–V chronic ulcers will be randomly allocated into two groups  Group A receiving leech therapy and Group B receiving PRP therapy once weekly for 8 weeks

Outcomes will be assessed through clinical parameters including wound size reduction wound healing rate pain score (VAS) granulation tissue formation and quality of life measures

 The study aims to compare the clinical outcomes of both therapies and evaluate the therapeutic potential of hirudotherapy as a safe and effective treatment option for chronic non-healing ulcers

 
Close